Lacosamide and myoclonic seizures: what is the risk of aggravation?

被引：4

作者：

Bosak, Magdalena ^{[1
]}

Wezyk, Kamil ^{[2
]}

Slowik, Agnieszka ^{[1
]}

机构：

[1] Jagiellonian Univ Krakow, Coll Med, Krakow, Poland

[2] Univ Hosp Krakow, Krakow, Poland

来源：

NEUROLOGIA I NEUROCHIRURGIA POLSKA | 2021年 / 55卷 / 01期

关键词：

lacosamide; myoclonic seizures; aggravation; exacerbation; TONIC-CLONIC SEIZURES;

D O I：

10.5603/PJNNS.a2021.0008

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：107 / 109

页数：3

共 8 条

[1]

Abarrategui B, 2017, EPILEPSY BEHAV CASE, V8, P63, DOI 10.1016/j.ebcr.2017.08.001

[2] Induction of epileptic negative myoclonus by addition of lacosamide to carbamazepine [J].

Belcastro, Vincenzo ;

Arnaboldi, Marco ;

Taborelli, Angelo ;

Prontera, Paolo .

EPILEPSY & BEHAVIOR, 2011, 20 (03) :589-590

[3]

Birnbaum D, 2017, EPILEPSY BEHAV CASE, V7, P28, DOI 10.1016/j.ebcr.2016.09.006

[4] Seizure aggravation in idiopathic generalized epilepsies [J].

Chaves, J ;

Sander, JW .

EPILEPSIA, 2005, 46 :133-139

[5]

Swaminathan A, 2015, NEUROLOGY, V84

[6] Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial [J].

Vossler, David G. ;

Knake, Susanne ;

O'Brien, Terence J. ;

Watanabe, Masako ;

Brock, Melissa ;

Steiniger-Brach, Bjorn ;

Williams, Paulette ;

Roebling, Robert .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2020, 91 (10) :1067-1075

[7] Lacosamide for uncontrolled primary generalized tonic-clonic seizures: An open-label pilot study with 59-week extension [J].

Wechsler, Robert T. ;

Yates, Stephen L. ;

Messenheimer, John ;

Leroy, Robert ;

Beller, Cynthia ;

Doty, Pamela .

EPILEPSY RESEARCH, 2017, 130 :13-20

[8] Predictors of remission in patients with epilepsy [J].

Wezyk, Kamil ;

Slowik, Agnieszka ;

Bosak, Magdalena .

NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2020, 54 (05) :434-439

← 1 →